Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NFH
1201
CALL
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $22.5M | 0.01% |
7,614,500
+189,500
| +3% | +$2.11M |
|
|
XLRN
1202
PUT
DELISTED
Acceleron Pharma
XLRN
| $22.3M | 0.01% |
+129,600
| New | +$17M |
|
1203
CenterPoint Energy
CNP
$28.3B
| $22.3M | 0.01% |
904,669
+545,778
| +152% | +$14M |
|
|
REVH
1204
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
| $22.2M | 0.01% |
2,291,156
+1,712,653
| +296% | +$16.7M |
|
1205
Travelers Companies
TRV
$81.1B
| $22.2M | 0.01% |
146,175
-71,780
| -33% | -$11.1M |
|
1206
Bumble
BMBL
$387M
| $22.2M | 0.01% |
443,891
+331,641
| +295% | +$17.2M |
|
1207
Bath & Body Works
BBWI
$3.97B
| $22.2M | 0.01% |
351,934
-220,524
| -39% | -$14M |
|
1208
Monolithic Power Systems
MPWR
$61.4B
| $22.2M | 0.01% |
45,751
+24,500
| +115% | +$11.1M |
|
|
RWT
1209
Redwood Trust
RWT
$588M
| $22.1M | 0.01% |
1,717,290
+1,215,554
| +242% | +$14.9M |
|
1210
Jefferies Financial Group
JEF
$12.7B
| $22.1M | 0.01% |
623,310
+495,385
| +387% | +$16.6M |
|
1211
Twilio
TWLO
$28.6B
| $22.1M | 0.01% |
69,224
-126,447
| -65% | -$46M |
|
|
APGB
1212
DELISTED
Apollo Strategic Growth Capital II
APGB
| $22.1M | 0.01% |
2,259,136
+973,205
| +76% | +$9.46M |
|
1213
Vail Resorts
MTN
$5.7B
| $22.1M | 0.01% |
66,055
+61,299
| +1,289% | +$18.9M |
|
1214
Toast
TOST
$18.9B
| $22M | 0.01% |
+441,409
| New | +$24.1M |
|
|
PINC
1215
DELISTED
Premier
PINC
| $22M | 0.01% |
567,509
+510,228
| +891% | +$18.8M |
|
1216
iShares MSCI South Korea ETF
EWY
$20.1B
| $22M | 0.01% |
+272,259
| New | +$23.7M |
|
1217
Elanco Animal Health
ELAN
$13.2B
| $21.9M | 0.01% |
686,279
-640,884
| -48% | -$21.5M |
|
1218
Petrobras
PBR
$120B
| $21.9M | 0.01% |
2,115,546
+1,670,871
| +376% | +$17.8M |
|
1219
Planet Labs
PL
$6.94B
| $21.9M | 0.01% |
2,206,102
+194,349
| +10% | +$1.92M |
|
1220
W.W. Grainger
GWW
$64.2B
| $21.8M | 0.01% |
55,505
-2,237
| -4% | -$971K |
|
|
WIRE
1221
DELISTED
Encore Wire Corp
WIRE
| $21.8M | 0.01% |
229,966
+148,654
| +183% | +$12.2M |
|
1222
Yum China
YUMC
$15.7B
| $21.8M | 0.01% |
372,792
+352,284
| +1,718% | +$21.7M |
|
|
EOSEW
1223
CALL
DELISTED
Eos Energy Enterprises Warrant
EOSEW
| $21.7M | 0.01% |
4,318,200
+534,990
| +14% | +$3.11M |
|
1224
KB Home
KBH
$3.5B
| $21.7M | 0.01% |
557,630
-915,810
| -62% | -$38M |
|
1225
Establishment Labs
ESTA
$2.71B
| $21.7M | 0.01% |
303,144
+188,134
| +164% | +$13.9M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.